Human Medicines Research and Development Support

  • Email
  • Help

The European Medicines Agency's Human Medicines Research and Development Support Division is in charge of providing scientific advice on all products and issues related to medicine development and proposing measures specifically aiming at fostering development of new medicines in orphan diseases and paediatric populations.

It is responsible for provision of regulatory intelligence to Agency staff, scientific bodies and interested parties throughout the medicinal-product lifecycle and coordinating the development of best evidence to support regulatory decision-making, manage research projects and scientific procurement, and liaising with research funding bodies.

An organisation chart shows the full structure of the Human Medicines Research and Development Support Division.

Head of Human Medicines Research and Development Support

Back to top

Head of Human Medicines Research and Development Support (ad interim)

Zaide FriasZaïde Frias

Nationality: Belgian / Portuguese

Career to date:

  • Head of Human Medicines Research and Development Support (ad interim), European Medicines Agency (2013-present)
  • Head of Regulatory Affairs and Best Evidence, European Medicines Agency (2013-present)
  • Head of Regulatory Affairs, European Medicines Agency (2009-2013)
  • Regulatory Affairs Adviser, European Medicines Agency (1999 -2009)
  • Regulatory Safety Officer, Pfizer SA, Brussels, Belgium (1996-1999)
  • Quality Control Supervisor, Pfizer SA, Brussels, Belgium (1995 -1996) 
  • Trainee, European Commission Directorate-General for Environment and Public Safety, Brussels, Belgium (1994-1995)
  • Community Pharmacist, Pharmacies Populaires de Bruxelles, Brussels, Belgium (1993)

Education:

Declaration of interests

Product Development Scientific Support

Back to top

Head of Product Development Scientific Support

Jordi LlinaresJordi Llinares Garcia

Nationality: Spanish

Career to date:

Education:

Declaration of interests

Head of Scientific Advice

Spiridon Vamvakas

Nationality: German / Greek

Career to date:

Education:

  • Board-certified physician for pharmacology and toxicology, Bavarian Chamber of Physicians, Munich, Germany (1994)
  • Habilitation for pharmacology and toxicology, University of Würzburg, Germany (1993)
  • Medical degree, University of Würzburg, Germany (1984)

Declaration of interests

Head of Paediatric Medicines

Paolo TomasiPaolo Tomasi

Nationality: Italian

Career to date:

Education:

Declaration of interests

Head of Orphan Medicines (ad interim)

Stiina Aarum Stiina Aarum

Nationality: Finnish

Career to date:

  • Head of Orphan Medicines (ad interim), European Medicines Agency (2013-present)
  • Scientific Administrator, European Medicines Agency (2007-2013)
  • Medical doctor, Karolinska University Hospital, Stockholm, Sweden (2003-2006)
  • Researcher, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden (2003-2004)
  • Investigator in clinical trials in osteoporosis, Horcon Oy, Helsinki, Finland (2001-2007)

Education:

Declaration of interests

Head of Regulatory Affairs and Best Evidence

Back to top

Head of Regulatory Affairs and Best Evidence

Zaide FriasZaïde Frias

Nationality: Belgian / Portuguese

Career to date:

  • Head of Regulatory Affairs and Best Evidence, European Medicines Agency (2013-present)
  • Head of Human Medicines Research and Development Support (ad interim), European Medicines Agency (2013-present)
  • Head of Regulatory Affairs, European Medicines Agency (2009-2013)
  • Regulatory Affairs Adviser, European Medicines Agency (1999 -2009)
  • Regulatory Safety Officer, Pfizer SA, Brussels, Belgium (1996-1999)
  • Quality Control Supervisor, Pfizer SA, Brussels, Belgium (1995 -1996) 
  • Trainee, European Commission Directorate-General for Environment and Public Safety, Brussels, Belgium (1994-1995)
  • Community Pharmacist, Pharmacies Populaires de Bruxelles, Brussels, Belgium (1993)

Education:

Declaration of interests

Head of Regulatory Affairs

To be appointed.

Head of Best Evidence Development

Henry FittHenry Fitt

Nationality: British

Career to date:

  • Head of Best Evidence Development, European Medicines Agency (2013-present)
  • Head of Coordination and Networking, European Medicines Agency (2009-2013)
  • Member, European Network of Centres in Pharmacoepidemiology and Pharmacovigilance Steering Group, European Medicines Agency (2009-present) 
  • Specialised Group Leader for Oncology, Blood, Cardiovascular and Diagnostic Products, European Medicines Agency (2006-2009)
  • Product Team Leader, European Medicines Agency (2000-2006)
  • Regulatory Affairs Executive, Nycomed Amersham, United Kingdom (1998-2000)
  • Regulatory Affairs Executive, Almirall Prodesfarma, Barcelona, Spain (1993-1998)

Education:

Declaration of interests